Mp16-02 phase iii trial of intravesical nadofaragene firadenovec in patients with high-grade, bcg-unresponsive, non-muscle invasive bladder cancer: two year follow-up in the ta/t1 cohort
Journal of Urology（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要